Mediplantex National Pharmaceutical JSC (HNX:MED)
20,400
0.00 (0.00%)
At close: Jan 30, 2026
HNX:MED Balance Sheet
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 24,401 | 42,611 | 43,534 | 81,183 | 46,107 |
Short-Term Investments | 6,700 | 12,000 | 20,000 | 92,400 | 48,400 |
Cash & Short-Term Investments | 31,101 | 54,611 | 63,534 | 173,583 | 94,507 |
Cash Growth | -43.05% | -14.04% | -63.40% | 83.67% | -12.15% |
Accounts Receivable | 39,275 | 66,896 | 90,917 | 127,297 | 113,221 |
Other Receivables | 187.06 | 4,377 | 2,776 | 12,614 | 20,472 |
Receivables | 39,462 | 71,273 | 93,693 | 139,911 | 133,694 |
Inventory | 92,808 | 87,540 | 102,920 | 102,221 | 87,933 |
Prepaid Expenses | - | 239.81 | 213.21 | 38.92 | 41.71 |
Other Current Assets | 40,877 | 39,417 | 40,509 | 42,719 | 25,935 |
Total Current Assets | 204,249 | 253,081 | 300,868 | 458,474 | 342,110 |
Property, Plant & Equipment | 212,824 | 212,121 | 214,196 | 181,186 | 109,257 |
Other Intangible Assets | 11.76 | 19.18 | 26.61 | 34.03 | - |
Other Long-Term Assets | 39,663 | 38,534 | 40,152 | 58,793 | 42,271 |
Total Assets | 456,747 | 503,755 | 555,243 | 698,487 | 493,638 |
Accounts Payable | 55,093 | 77,962 | 74,430 | 84,885 | 41,394 |
Accrued Expenses | 18,999 | 14,827 | 15,950 | 14,771 | 8,501 |
Short-Term Debt | 33,914 | 27,787 | 64,463 | 90,835 | 68,595 |
Current Income Taxes Payable | - | 948.94 | 651.91 | 2,393 | 1,430 |
Current Unearned Revenue | 15,436 | 15,994 | 29,637 | - | - |
Other Current Liabilities | 2,557 | 35,373 | 42,914 | 183,602 | 207,937 |
Total Current Liabilities | 125,998 | 172,892 | 228,046 | 376,486 | 327,857 |
Other Long-Term Liabilities | 0 | - | - | - | - |
Total Liabilities | 125,998 | 172,892 | 228,046 | 376,486 | 327,857 |
Common Stock | 124,100 | 124,100 | 124,100 | 124,100 | 62,801 |
Additional Paid-In Capital | 121,230 | 121,230 | 121,230 | 121,230 | 29,425 |
Retained Earnings | 85,420 | 85,533 | 81,867 | 76,671 | 73,536 |
Comprehensive Income & Other | - | - | - | - | 18.33 |
Shareholders' Equity | 330,750 | 330,863 | 327,197 | 322,002 | 165,780 |
Total Liabilities & Equity | 456,747 | 503,755 | 555,243 | 698,487 | 493,638 |
Total Debt | 33,914 | 27,787 | 64,463 | 90,835 | 68,595 |
Net Cash (Debt) | -2,813 | 26,824 | -929.58 | 82,748 | 25,912 |
Net Cash Growth | - | - | - | 219.34% | -3.94% |
Net Cash Per Share | -226.72 | 2161.51 | -74.91 | 8813.28 | 4128.39 |
Filing Date Shares Outstanding | 12.41 | 12.41 | 12.43 | 12.41 | 6.28 |
Total Common Shares Outstanding | 12.41 | 12.41 | 12.43 | 12.41 | 6.28 |
Working Capital | 78,251 | 80,189 | 72,822 | 81,988 | 14,253 |
Book Value Per Share | 26651.87 | 26661.01 | 26331.15 | 25946.94 | 26397.75 |
Tangible Book Value | 330,738 | 330,844 | 327,170 | 321,968 | 165,780 |
Tangible Book Value Per Share | 26650.92 | 26659.47 | 26329.01 | 25944.20 | 26397.75 |
Buildings | 47,111 | 47,111 | 47,111 | - | - |
Machinery | 111,967 | 107,117 | 105,558 | - | - |
Construction In Progress | 180,595 | 177,699 | 173,769 | 130,085 | 67,159 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.